Integration of Clinical Pharmacy Along the Entire Care Pathway of Patients Implanted With a PICC-line
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Catheter Complications
- Sponsor
- University Hospital, Toulouse
- Enrollment
- 138
- Locations
- 1
- Primary Endpoint
- Assessment of the number of complications during the interventional phase.
- Last Updated
- 3 years ago
Overview
Brief Summary
Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.
The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.
Detailed Description
This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patient, age equal to or older than 18 years old
- •Patient capable of giving free and informed consent
- •Patient insured by the Social Security System
- •Patient living at home
- •Patient with a PICC line prescription
- •Patient whose discharge prescription should contain drugs and MDs
- •Patient for home discharge implanted with a PICC line
- •Patient reachable by phone
Exclusion Criteria
- •Under aged patient, age under 18 years old
- •Uninsured patient by the Social Security System
- •Patient not living at home :
- •Institutionalized patient
- •Patient living in a home for elderly dependent persons
- •Nursing home resident
- •Home-hospitalized patient
- •Patient deprived of liberty by a judicial or administrative decision
- •Patient under guardianship, curatorship or safeguard of justice
- •Patient unreachable by phone
Outcomes
Primary Outcomes
Assessment of the number of complications during the interventional phase.
Time Frame: 3 months
Number of complications per patient and per month in each group. Number of complications per patient and per month in each group
Secondary Outcomes
- Number of consultations and rehospitalizations post-discharge.(3 months)
- Conformity analysis of the PICC line logistic circuit(day 0)
- Conformity analysis of hospital prescriptions issued in town.(day 0)
- healthcare professionals satisfaction survey(3 months)
- Conformity analysis of treatment indication.(day 0)
- Direct hospital costs.(3 months)
- Participants satisfaction survey(3 months)
- Acceptance rate of pharmaceutical interventions (PI) during interventional phase and evaluation of PIs' criticality.(3 months)
- Patient's Quality Of Life assessment(3 months)